Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIAT
Ratios

Cullinan Therapeutics (CGEM) Shares Repurchased (2020)

Cullinan Therapeutics (CGEM) has 1 years of Shares Repurchased data on record, last reported at $6.4 million in Q4 2020.

  • For Q4 2020, Shares Repurchased changed N/A year-over-year to $6.4 million; the TTM value through Dec 2020 reached $6.6 million, changed N/A, while the annual FY2020 figure was $6.6 million, N/A changed from the prior year.
  • Shares Repurchased reached $6.4 million in Q4 2020 per CGEM's latest filing, up from $213000.0 in the prior quarter.
  • Across five years, Shares Repurchased topped out at $6.4 million in Q4 2020 and bottomed at $213000.0 in Q1 2020.